194 related articles for article (PubMed ID: 26808260)
21. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A
J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810
[TBL] [Abstract][Full Text] [Related]
22. Co-chaperone HSJ1a dually regulates the proteasomal degradation of ataxin-3.
Gao XC; Zhou CJ; Zhou ZR; Zhang YH; Zheng XM; Song AX; Hu HY
PLoS One; 2011; 6(5):e19763. PubMed ID: 21625540
[TBL] [Abstract][Full Text] [Related]
23. The Machado-Joseph disease-associated form of ataxin-3 impacts dynamics of clathrin-coated pits.
Rosselli-Murai LK; Joseph JG; Lopes-Cendes I; Liu AP; Murai MJ
Cell Biol Int; 2020 May; 44(5):1252-1259. PubMed ID: 31970864
[TBL] [Abstract][Full Text] [Related]
24. Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3.
Wang Q; Li L; Ye Y
J Cell Biol; 2006 Sep; 174(7):963-71. PubMed ID: 17000876
[TBL] [Abstract][Full Text] [Related]
25. Activation of the membrane-bound Nrf1 transcription factor by USP19, a ubiquitin-specific protease C-terminally anchored in the endoplasmic reticulum.
Hu S; Xiang Y; Qiu L; Wang M; Zhang Y
Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119299. PubMed ID: 35613680
[TBL] [Abstract][Full Text] [Related]
26. Aqueous extract of Gardenia jasminoides targeting oxidative stress to reduce polyQ aggregation in cell models of spinocerebellar ataxia 3.
Chang KH; Chen WL; Wu YR; Lin TH; Wu YC; Chao CY; Lin JY; Lee LC; Chen YC; Lee-Chen GJ; Chen CM
Neuropharmacology; 2014 Jun; 81():166-75. PubMed ID: 24486383
[TBL] [Abstract][Full Text] [Related]
27. A model for small heat shock protein inhibition of polyglutamine aggregation.
Healy EF; Little C; King PJ
Cell Biochem Biophys; 2014 Jun; 69(2):275-81. PubMed ID: 24242192
[TBL] [Abstract][Full Text] [Related]
28. [Polyglutamine-expanded ataxin-3 is degraded by autophagy].
Xiao H; Tang J; Hu Z; Tan J; Tang B; Jiang Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):23-8. PubMed ID: 20140862
[TBL] [Abstract][Full Text] [Related]
29. Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3.
Berke SJ; Chai Y; Marrs GL; Wen H; Paulson HL
J Biol Chem; 2005 Sep; 280(36):32026-34. PubMed ID: 16040601
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin ligase ITCH recruitment suppresses the aggregation and cellular toxicity of cytoplasmic misfolded proteins.
Chhangani D; Upadhyay A; Amanullah A; Joshi V; Mishra A
Sci Rep; 2014 May; 4():5077. PubMed ID: 24865853
[TBL] [Abstract][Full Text] [Related]
31. The type II deiodinase is retrotranslocated to the cytoplasm and proteasomes via p97/Atx3 complex.
Arrojo E Drigo R; Egri P; Jo S; Gereben B; Bianco AC
Mol Endocrinol; 2013 Dec; 27(12):2105-15. PubMed ID: 24196352
[TBL] [Abstract][Full Text] [Related]
32. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.
Haacke A; Broadley SA; Boteva R; Tzvetkov N; Hartl FU; Breuer P
Hum Mol Genet; 2006 Feb; 15(4):555-68. PubMed ID: 16407371
[TBL] [Abstract][Full Text] [Related]
33. Degron capability of the hydrophobic C-terminus of the polyglutamine disease protein, ataxin-3.
Blount JR; Johnson SL; Libohova K; Todi SV; Tsou WL
J Neurosci Res; 2020 Oct; 98(10):2096-2108. PubMed ID: 32643791
[TBL] [Abstract][Full Text] [Related]
34. Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1.
Meriin AB; Mabuchi K; Gabai VL; Yaglom JA; Kazantsev A; Sherman MY
J Cell Biol; 2001 May; 153(4):851-64. PubMed ID: 11352944
[TBL] [Abstract][Full Text] [Related]
35. Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3.
Todi SV; Winborn BJ; Scaglione KM; Blount JR; Travis SM; Paulson HL
EMBO J; 2009 Feb; 28(4):372-82. PubMed ID: 19153604
[TBL] [Abstract][Full Text] [Related]
36. An N-terminal SIAH-interacting motif regulates the stability of the ubiquitin specific protease (USP)-19.
Velasco K; Zhao B; Callegari S; Altun M; Liu H; Hassink G; Masucci MG; Lindsten K
Biochem Biophys Res Commun; 2013 Apr; 433(4):390-5. PubMed ID: 23500468
[TBL] [Abstract][Full Text] [Related]
37. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of ataxin-3 by glycogen synthase kinase 3beta at serine 256 regulates the aggregation of ataxin-3.
Fei E; Jia N; Zhang T; Ma X; Wang H; Liu C; Zhang W; Ding L; Nukina N; Wang G
Biochem Biophys Res Commun; 2007 Jun; 357(2):487-92. PubMed ID: 17434145
[TBL] [Abstract][Full Text] [Related]
39. The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster.
Tsou WL; Ouyang M; Hosking RR; Sutton JR; Blount JR; Burr AA; Todi SV
Neurobiol Dis; 2015 Oct; 82():12-21. PubMed ID: 26007638
[TBL] [Abstract][Full Text] [Related]
40. The USP19 deubiquitinase regulates the stability of c-IAP1 and c-IAP2.
Mei Y; Hahn AA; Hu S; Yang X
J Biol Chem; 2011 Oct; 286(41):35380-35387. PubMed ID: 21849505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
